-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
Intellipharmaceutics International Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from 2010 to Q3 2023.
- Intellipharmaceutics International Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending August 31, 2023 was -$1.89M, a 538% decline year-over-year.
- Intellipharmaceutics International Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2015 was -$7.44M, a 92.8% decline from 2014.
- Intellipharmaceutics International Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2014 was -$3.86M, a 64.8% increase from 2013.
- Intellipharmaceutics International Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2013 was -$11M, a 75.2% decline from 2012.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Growth (%)